VenstraMedical announced that it secured an investment to accelerate the development of its percutaneous ventricular assist ...

MedStar Washington Hospital Center has reached a major milestone in cardiac care by completing more than 500 HeartMate 3 Left ...

VenstraMedical Secures Investment From Highcroft Capital to Advance Next-generation Cardiac Support Device ...

OverviewThe global vascular access device (VAD) market is projected to grow steadily at a CAGR of ~6% during the forecast ...

EBR Systems, Inc., developer of the world's only left ventricular wireless cardiac pacing device for heart failure, today announced that management will be participating at the Piper Sandler 37 (th) ...

By the time Marc Pierre arrived at Jackson Memorial Hospital in 2021, his heart was failing fast. At just 36, he was in cardiogenic shock, a life-threatening condition where the ...

In early November 2025, a quote attributed to U.S. President Donald Trump spread on social media in which he allegedly ...

About VIVO ™ Catheter Precision’s VIVO (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, ...

Articles and videos about Sen. John Fetterman suffers fall after ventricular fibrillation flare-up: spokesperson on FOX 5 DC.

EBR’s US launch is young, but early adoption and bullish broker upgrades are turning it into a medtech stock to watch.

-- Peer-reviewed data published in Neurosurgery show that SOLOPASS (R) 2.0 delivers significantly higher accuracy than free-hand EVD placement. -- SOLOPASS (R) 2.0 achieved consistent accuracy across ...

Medtronic (NYSE: MDT) today announced new data supporting its Aurora and OmniaSecure defibrillation technology offerings.